Surav Dilek B, Hanci Ayse, Sivrikaya G Ulufer, Bektas Metin, Kilinc Leyla T
Department of Anesthesiology, Kandira State Hospital, Kandira, Turkey.
Department of Second Anesthesiology and Reanimation, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Curr Ther Res Clin Exp. 2011 Apr;72(2):71-8. doi: 10.1016/j.curtheres.2011.03.002.
Levobupivacaine, the S(-) isomer of bupivacaine, is less cardiotoxic than racemic bupivacaine. Previous studies have examined different concentrations of levobupivacaine in similar ways.
This prospective, randomized, double-blind study was designed to determine the clinical efficacy and hemodynamic effects of different concentrations and equivalent volumes of levobupivacaine in epidural anesthesia. To our knowledge, this is the first study to evaluate the effects of concentration lower than 0.5% levobupivacaine.
Forty adult patients with an American Society of Anesthesiology (ASA) I-III physical status undergoing transurethral endoscopic surgery were randomly divided into 2 groups to receive either 10 mL of isobaric levobupivacaine (0.5% + 5 mL 0.9% saline [group 1; n = 20]) or 10 mL of isobaric levobupivacaine (0.75% + 5 mL saline 0.9% saline [group 2; n = 20]) for epidural anesthesia. An observer blinded to group division evaluated the time of onset, maximum level, and time to 2-segment regression of sensory block.
There were no differences between the 2 groups in terms of hemodynamic parameters and time of onset of the sensory block. There were significant differences, however, between the 2 groups in the maximum level of the sensory block (group 1, T9; group 2, T8; P = 0.010) and the time to 2-segment regression of sensory block (group 1, 46.35 minutes; group 2, 62.94 minutes; P = 0.013).
This study indicated that 10 mL of 0.5% levobupivacaine plus 5 mL of 0.9% saline is a suitable solution for use in epidural anesthesia because it produces a block clinically comparable to that of 10 mL of 0.75% levobupivacaine plus 5 mL of 0.9% saline for transurethral resection of prostate surgery.
左旋布比卡因是布比卡因的S(-)异构体,其心脏毒性低于消旋布比卡因。以往的研究以类似方式研究了不同浓度的左旋布比卡因。
本前瞻性、随机、双盲研究旨在确定不同浓度和等体积的左旋布比卡因在硬膜外麻醉中的临床疗效和血流动力学效应。据我们所知,这是第一项评估浓度低于0.5%的左旋布比卡因效果的研究。
40例美国麻醉医师协会(ASA)身体状况为I-III级的成年患者,接受经尿道内镜手术,随机分为2组,分别接受10 mL等比重左旋布比卡因(0.5% + 5 mL 0.9%生理盐水[第1组;n = 20])或10 mL等比重左旋布比卡因(0.75% + 5 mL 0.9%生理盐水[第2组;n = 20])用于硬膜外麻醉。一名对分组不知情的观察者评估感觉阻滞的起效时间、最高平面和感觉阻滞消退两个节段的时间。
两组在血流动力学参数和感觉阻滞起效时间方面无差异。然而,两组在感觉阻滞的最高平面(第1组,T9;第2组,T8;P = 0.010)和感觉阻滞消退两个节段的时间(第1组,46.35分钟;第2组,62.94分钟;P = 0.013)方面存在显著差异。
本研究表明,10 mL 0.5%左旋布比卡因加5 mL 0.9%生理盐水是硬膜外麻醉的合适溶液,因为对于前列腺手术经尿道切除术,其产生的阻滞在临床上与10 mL 0.75%左旋布比卡因加5 mL 0.9%生理盐水相当。